The global Automated Breast Ultrasound Systems market was worth around USD 792.70 billion in 2021 and is estimated to grow to about USD 1911.43 billion by 2028, with a compound annual growth rate (CAGR) of approximately 15.80 percent over the forecast period.
The global Automated Breast Ultrasound Systems market was worth around USD 792.70 billion in 2021 and is estimated to grow to about USD 1911.43 billion by 2028, with a compound annual growth rate (CAGR) of approximately 15.80 percent over the forecast period. The report analyzes the Automated Breast Ultrasound Systems market’s drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the Automated Breast Ultrasound Systems market.
Automated Breast Ultrasound Systems Market: Overview
Breast cancer is one of the most frequent cancers in the world, and it is a severe health concern because it is the most common cancer in women. As a result, healthcare practitioners place a premium on early detection in order to lower morbidity and mortality rates and improve survival rates. Mammography and ultrasound are well-known tools for breast cancer screening and early detection. When used in conjunction with mammography, the breast ultrasound system has shown encouraging results in the diagnosis of tumours in women with thick breasts. Both mammography and conventional breast ultrasonography, on the other hand, had some technical limitations, paving the path for the development of ABUS.
The automated breast ultrasound (ABUS) system is a new technological advancement in the field of ultrasound imaging that was created to provide an operator-free system. ABUS is a repeatable system that produces high-resolution three-dimensional imaging. ABUS is known for its comfort, accuracy, and efficiency in handling. ABUS has been shown in several studies and research to have higher sensitivity, cancer detection rates, diagnostic accuracy rates, and picture quality. With the use of high-frequency transducers, recent improvements in ABUS systems have made it possible to reproduce superior quality images in a short amount of time.
The demand for automated breast ultrasound systems is being fueled by rising breast cancer prevalence and occurrences, a developing radiology market, and greater patient knowledge of the link between breast density and breast cancer. Furthermore, technological advancements in the development of improved imaging techniques, as well as increased government funding for breast cancer awareness, should boost market demand. Furthermore, heavy investments and extensive research, as well as the advantages of automated breast ultrasound systems such as 3D imaging, high quality imaging, coronal view, and rapid results with assurance of improved diagnostic results, are propelling the market for automated breast ultrasound systems forward. With an increase in the number of instances of breast cancer each year, particularly among women, and rising healthcare costs, the market for automated breast ultrasound systems (ABUS) is expected to rise rapidly in the future years.
The COVID-19 pandemic has turned into a humanitarian and economic disaster, straining society and harming millions of people and businesses. Healthcare organisations are already planning new plans to respond to the rising number of COVID-19 patients, from locating speedy diagnostic kits to ensuring that personnel have adequate PPE. According to Chinese studies, cancer patients are at higher risk because they are prone to SARS-CoV-2 and have a higher likelihood of becoming infected with the virus. Due to the medical field's focus on COVID-19, funding for R&D efforts connected to automated breasts ultrasound has been cut, and this segment has been neglected, resulting in a negative impact on the market for automated breasts ultrasound systems.
Automated Breast Ultrasound Systems Market: Growth Drivers
Demands for automated breast ultrasound systems to drive global market growth
Breast cancer is the fifth biggest cause of mortality among women from cancer. Breast cancer affects as least one out of every four women diagnosed with cancer, and this worrying increase has prompted the need for efficient therapy. The ever-increasing prevalence of breast cancer around the world has sparked a spike in demand for automated breast ultrasonography equipment. The market for automated breast ultrasonography systems is growing due to an increase in the incidence of hereditary illnesses in women, as well as rising healthcare spending and favorable government regulations. According to the American Cancer Society, roughly 1.7 million new cancer cases are expected to be diagnosed by 2018, with over 600,000 Americans expected to die from cancer. The market for automated breast ultrasound systems has been boosted by increased R&D spending. Cancer Research UK has invested USD 518 million in cancer research across the country, with the goal of increasing cancer survival rates by 75% by 2034. By 2023, the group wants to spend up to 2.6 percent of GDP on cancer research. In addition, rising per capita income, favorable reimbursement policies, and increased knowledge of diagnostic system availability have supported the expansion of the automated breast ultrasound systems market.
Automated Breast Ultrasound Systems Market: Restraints
Stringent regulations in various countries in Automated Breast Ultrasound Systems to hamper the market growth
The use of imaging techniques has been restricted in a number of countries due to strict laws. Furthermore, the high cost of ultrasound systems compared to traditional cancer screening methods is expected to limit the growth of the global automated breast ultrasound system (ABUS) market. A new ABUS, for example, can cost around $300,000 on average. Although ultrasonography is quick and effective in detecting cancer, it is prone to false-positive biopsies, which is expected to slow market growth.
Automated Breast Ultrasound Systems Market: Opportunities
Demands for automated breast ultrasound systems to bring growth opportunities for global market
The number of patients is growing, and to diagnose any sort of cancer, an ultrasound or MRI is required to determine the cause or which body part is afflicted, which is positively impacting demand for breast ultrasound systems. Furthermore, the automated breast ultrasound systems market is influenced by the rise in healthcare expenditure, advancements in technology provided by different market players, advancements in healthcare infrastructure, and ore portable and less expensive diagnostic imaging tool, as compared to CT and MRI, breast associated disorder.
Global Automated Breast Ultrasound Systems Market: Segmentation
The global Automated Breast Ultrasound Systems market is segregated based on product, application, end user and region.
By product, the market is classified into Automated Breast Ultrasound System amd Automated Breast Volume Scanner. By 2028, the automated breast ultrasound system segment is expected to grow at a faster rate. One of the primary factors boosting the worldwide automated breast ultrasound system is technological advances in breast cancer detection equipment. Several additional technologies are being developed by companies to improve cancer screening in people with thick breasts, enhancing the efficiency of breast cancer detection. ABUS innovations are also expected to solve flaws in traditional systems. Customer acceptance of improved cancer imaging will increase as a result of such technological advancements, boosting industry growth..
By end user, the Automated Breast Ultrasound Systems market is segmented into hospitals,diagonostic centers and ambulatory surgery centers. The diagnostic imaging centres segment will have a larger share in the forecasted period. The segmental growth will be accelerated by the expansion of diagnostic centre facilities for early identification and detection of malignant cells in the body. Breast cancer detection technologies will be adopted at a faster pace as specialist diagnosis tools and technology become more widely available. Furthermore, throughout the forecast period, improving infrastructure in diagnostic imaging centres in developing countries will support segmental growth.
|Historic Years||2016 - 2020|
|Forecast Years||2021 - 2028|
|Segments Covered||By Product Type, By Application, and By End Use|
|Forecast Units||Value (USD Billion), and Volume (Units)|
|Quantitative Units||Revenue in USD million/billion and CAGR from 2021 to 2028|
|Regions Covered||North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World|
|Countries Covered||U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others|
|Number of Companies Covered||10 companies with scope for including additional 15 companies upon request|
|Report Coverage||Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.|
|Customization Scope||Avail customized purchase options to meet your exact research needs.|
According to the American Society of Cancer, about 281,550 new instances of breast cancer will be discovered in women in 2021, with 43,600 women dying from the disease. Breast cancer is becoming more common, which will increase the demand for better breast imaging technology and therapies. The ABUS market in the United States will be boosted by increased government programmes to raise awareness and educate women about breast cancer and the necessity of screening. The American Society of Cancer's National Breast Cancer Awareness (NBCA) month, the National Breast Cancer Foundation's awareness campaigns, and the Susan Komen Foundation’s. These factors will boost demand for automated breast ultrasonography devices for breast cancer screening in dense breast tissue.
Some of the main competitors dominating the global Automated Breast Ultrasound Systems market include - Canon Medical System, GE Healthcare,Hitachi Ltd., koninklijke Philips N.V, Metritrack Inc., Nova Medical Imaging Technology Co. Ltd, Qview Medical Inc., SonoCine Inc. and SuperSonic Imgine.
Global Automated Breast Ultrasound Systems market is segmented as follows:
Automated breast ultrasound system (ABUS) captures ultrasound images of the breasts through a transducer, which helps in scanning the whole breast. It also provides 3D images of dense breast tissues for cancer detection. Automated breast ultrasound inspection offers benefits including 3D images and coronal view, less turnaround time, and improved diagnostics solutions. Key companies, such as Siemens Healthcare, SonoCine, and U-Systems Inc., have developed an automated breast ultrasound system, the latest technology, as a substitute for conventional hand-held ultrasounds for supplemental use. Some automated breast ultrasound systems take only seven minutes to perform a bilateral exam, which is half the time taken by traditional ultrasound systems. An automated breast ultrasound system contains a transducer without human intervention and it scans the breast, which reduces operator dependency. This is a user-friendly system, with a touchscreen, intelligent imaging algorithms, a transducer shaped for a woman’s anatomy, and automated compression, that provides efficient reading and analysis.
According to the World Health Organization (WHO), breast cancer is the most widespread cancer among women globally. Breast cancer is the second foremost reason for death among women across the globe. As per National Breast Cancer Foundation statistics, it is projected that in the U.S., each year nearly 252,710 women are diagnosed with breast cancer and approximately 40,500 women die. In the U.S., one in eight women is diagnosed with breast cancer. Even though breast cancer in men is less frequent, an estimated 2,470 men are diagnosed with breast cancer and approximately 460 die each year. More than 3.3 million people are living with breast cancer in the U.S. alone today. The automated breast ultrasound systems market is growing rapidly due to the increase in breast cancer cases among women and increased number of women undergoing breast cancer screening. Additionally, availability of funds to install relatively expensive ABUSis likely to support the automated breast ultrasound systems market. However, the high cost of automated breast ultrasound systems might be a restraint for market growth. Additionally, lengthy test durations and a shortage of trained and skilled specialists and professionals for operating the tools can hamper this market’s growth. Growing incidences of breast cancer witnessed across the globe is anticipated to generate lucrative opportunities for the automated breast ultrasound systems market in the future.
The automated breast ultrasound systems market is divided based on product, application, and end-user. By product, the automated breast ultrasound systems market is categorized into an automated breast ultrasound system and automated breast volume scanner. The automated breast ultrasound system (ABUS) segment is projected to dominate in the future, due to the advantages like uniformity, high reproducibility, and high-resolution images. Thus, this segment is likely to contribute significantly toward business growth in this market. By application, the automated breast ultrasound systems market is bifurcated into screening and pre-operative evaluation. By end-user, the automated breast ultrasound systems market is divided into hospitals, ambulatory surgical units, and diagnostic centers.
By geography, North America dominates the global automated breast ultrasound systems market due to the growing rate of breast cancer and favorable regulatory policies. In the U.S., the increased number of women undergoing breast screening has resulted in the expansion of the automated breast ultrasound systems market. In the Asia Pacific region, ever-increasing awareness toward identifying breast cancer at the primary stage and high expenditure related to research and development activities to upgrade technologies for accurate results are driving the market across this region. Japan, China, and India have displayed positive growth for this market across the Asia Pacific region. Latin America is another important regional market and is estimated to register moderate growth in the future, due to the rising presence of hospitals and diagnostic centers for breast cancers and increasing awareness about breast cancer among the people. The Middle East and Africa market are anticipated to witness a significant growth in the forecast timeframe.
Some key players in the automated breast ultrasound systems marketincludeKoninklijke Philips N.V, Siemens AG, SonoCine. Inc., iVu Imaging Corporation, Hitachi Ltd., General Electric Company, Delphinus Medical Technologies, Inc., and Hitachi, Ltd., among others.
Rising breast cancer prevalence and occurrences, a growing radiology industry, and more patient awareness of the link between breast density and breast cancer are all driving demand for automated breast ultrasound systems. Furthermore, market demand should be boosted by technological developments in the development of superior imaging techniques, as well as greater government financing for breast cancer awareness..
According to the Market Research report, the global Automated Breast Ultrasound Systems market was worth about 792.70 (USD billion) in 2021 and is predicted to grow to around 1911.43 (USD billion) by 2028, with a compound annual growth rate (CAGR) of around 15.80 percent.
North America leads the global Automated Breast Ultrasound Systems market because according to the American Society of Cancer, women will be diagnosed with 281,550 new cases of breast cancer in 2021, with 43,600 women dying from the disease. As breast cancer becomes more widespread, the demand for better breast imaging technology and therapies will rise. Increased government programmes to raise awareness and educate women about breast cancer and the importance of screening will boost the ABUS market in the United States.